Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for Pediatric Opsoclonus-Myoclonus Syndrome
NCT00244361Phase 2Completed
- Start
- Jun 2005
- Primary completion
- Dec 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in Opsoclonus myoclonus syndrome (OMS). Started Jun 2005; status: completed.
02
Drugs
rituximab
03
Conditions
Opsoclonus myoclonus syndrome (OMS)
Beyond the preview
Go deeper on NCT00244361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244361.